Correspondence 0001193125-23-272403 from CARGO Therapeutics, Inc. (CRGX) (CIK 0001966494)
CARGO Therapeutics, Inc. (CRGX) (CIK 0001966494)
Date: Nov. 7, 2023 · CIK: 0001966494 · Accession: 0001193125-23-272403
AI Filing Summary & Sentiment
File numbers found in text: 333-275113
Show Raw Text
CORRESP 1 filename1.htm CORRESP November 7, 2023 United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, DC 20549 Attention: Christine Torney Mary Mast Jimmy McNamara Tim Buchmiller Re: CARGO Therapeutics, Inc. (the “Registrant”) Registration Statement on Form S-1 (File No. 333-275113) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between November 6, 2023 and the date hereof, approximately 765 copies of the Preliminary Prospectus, dated November 6, 2023, were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement, as amended. We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. We hereby join in the request of the Registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Thursday, November 9, 2023 or as soon thereafter as practicable. [signature page follows] Very truly yours, J.P. MORGAN SECURITIES LLC JEFFERIES LLC COWEN AND COMPANY, LLC As representatives of the Underwriters J.P. MORGAN SECURITIES LLC By: /s/ Benjamin Burdett Name: Benjamin Burdett Title: Managing Director, Head of Healthcare ECM JEFFERIES LLC By: /s/ Michael Brinkman Name: Michael Brinkman Title: Managing Director COWEN AND COMPANY, LLC By: /s/ Bill Follis Name: Bill Follis Title: Managing Director [Signature Page to Acceleration Request Letter]